Tilray Inc. (TLRY) saw its stock surge 5.23% in Sunday's trading session, following a bullish analyst report from TD Cowen. The cannabis company's shares received a significant boost after analyst Robert Moskow reiterated a Buy rating on Tilray and substantially increased the price target from $0.80 to $2.50.

The upgrade comes as a vote of confidence in Tilray's growth potential and strategic market positioning. Moskow's decision to maintain a Buy rating while more than tripling the price target suggests a notably improved outlook for the company's future prospects. This positive assessment from a reputable analyst firm has evidently resonated with investors, driving the stock's impressive intraday performance.

For Tilray shareholders and potential investors, this development may signal renewed optimism in the company's trajectory. However, it's important to note that while analyst ratings can influence stock prices in the short term, investors should always consider a wide range of factors, including the company's financials, industry trends, and overall market conditions, before making investment decisions.